Click here to stream the public defence
Due to copyright issues, an electronic copy of the thesis must be ordered from the faculty. For the faculty to have time to process the order, the order must be received by the faculty at the latest 2 days before the public defence. Orders received later than 2 days before the defence will not be processed. After the public defence, please address any inquiries regarding the thesis to the candidate.
Trial Lecture – time and place
See Trial Lecture.
Adjudication committee
- First opponent: Professor Lore Decoster, Vrije Universiteit Brussel, Belgium
- Second opponent: PhD, MD Håkon Ihle-Hansen, Bærum Sykehus,
- Third member and chair of the evaluation committee: Professor Anne Hansen Ree, University of Oslo
Chair of the Defence
Professor II Odd Terje Brustugun, University of Oslo
Principal Supervisor
Professor Emerita Marit Slaaen, University of Oslo
Summary
The number of older patients with cancer is rapidly increasing and they exhibit large variation in health status. With age, physiological and functional reserves gradually decline, and can lead to a state of increased vulnerability to stressors known as frailty. To identify frailty and individualize the management of older patients with cancer, a geriatric assessment (GA) is recommended. GA is a systematic evaluation of domains where older adults commonly have problems such as comorbidity, polypharmacy, nutritional status, physical function, functional status, and psychosocial function.
The objectives of this thesis were to investigate how geriatric impairments as identified by GA influence survival, quality of life (QoL) and physical function, and to explore cognitive trajectories among older patients with cancer receiving radiotherapy (RT).
A prospective observational study including 301 patients ≥65 years refereed to RT with curative or palliative intent was conducted. GA was performed before and repeatedly after RT, and patients answered questionnaires assessing QoL and functioning.
Nutritional deficiencies and poor functional status were associated with reduced survival. Moreover, survival declined with increasing number of geriatric impairments. Patient’s QoL, physical- and cognitive function remained relatively stable during follow-up. However, with increasing number of impairments patients consistently reported poorer QoL and physical function.
In conclusion, older patients tolerated radiotherapy well, but those with several accumulated geriatric impairments were at risk of poor outcomes. The gradual decline in survival, QoL and physical function with increasing number of impairments indicate that frailty represents a continuum of increased vulnerability. This is essential because interventions aiming to ameliorate impairments may prevent further decline, and have the potential to improve outcomes for older patients with cancer.
Additional information
Contact the research support staff.